FIELD: chemistry.
SUBSTANCE: invention relates to compounds of formula (I) where: R1 denotes C1-C10alkyl, C3-C10cycloalkyl; R3 denotes H, halide; R4 denotes a 6-member monocyclic heteroaryl containing 1-2 nitrogen atoms, one of which can be oxidised, optionally substituted with a halide; n ranges from 0 to 3; provided that R1 denotes C3-C10cycloalkyl and/or R4 denotes a 6-member monocyclic heteroaryl optionally substituted with a halide and containing 2 ring N heteroatoms, one of which can be oxidised or pharmaceutically acceptable salt thereof.
EFFECT: obtaining peptidyl deformylase (PDF) inhibiting compounds.
12 cl, 24 ex
Title | Year | Author | Number |
---|---|---|---|
(3-CYCLOALKYL-2, 3, 4, 5 - TETRAHYDRO-1H-BENZO [d] AZEPIN-7-YLOXY) DERIVATIVES, USE THEREOF FOR INHIBITING H3 RECEPTORS, PHARMACEUTICAL COMPOSITION AND PREPARATION METHOD | 2003 |
|
RU2388752C2 |
DERIVATIVES OF DIHYDROBENZO[b][1,4]DIAZEPINE-2-ONE AS ANTAGONISTS OF MGLUR2 II | 2002 |
|
RU2263112C2 |
COMPOUNDS, PHARMACEUTICAL COMPOSITIONS CONTAINING THEREOF AND METHOD FOR TREATMENT OF CYTOKINE-MEDIATED DISEASE | 2000 |
|
RU2298008C2 |
NEW ETERIAL DERIVATIVES OF ISOXAZOLE AS POSITIVE ALLOSTERIC MODULATORS OF THE GABA A ALFA 5 RECEPTOR | 2017 |
|
RU2772862C2 |
COMPOUNDS USEFUL AS ANTI-INFLAMMATORY AGENTS | 2000 |
|
RU2242474C2 |
IMIDAZOPYRROLOPYRAZINE DERIVATIVES, USEFUL FOR TREATMENT OF DISEASES, CAUSED BY ABNORMAL ACTIVITY OF PROTEINKINASES Jak1, Jak3 OR Syk | 2010 |
|
RU2570416C2 |
SUBSTITUTED HETEROCYCLIC SULPHONAMIDE COMPOUNDS USEFUL AS TRPA1 MODULATORS | 2014 |
|
RU2675792C2 |
5-AMINOCYCLYLMETHYLOXAZOLIDIN-2-ONE DERIVATIVES | 2008 |
|
RU2492169C2 |
CXCR7 ANTAGONISTS | 2013 |
|
RU2649004C2 |
GLUCOKINASE ACTIVATORS AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM AS ACTIVE INGREDIENT | 2008 |
|
RU2450001C2 |
Authors
Dates
2011-02-27—Published
2006-05-22—Filed